BESORFIB

Warner-Lambert Company LLC

Application Filed: 2010-12-29

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	85207037
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Katrina Edge
Attorney Docket Number	BESORFIB / U
Law Office Assigned	M70
Employee Name	SWAIN, MICHELE LYNN

Timeline

2010-12-29	Application Filed
2011-03-22	Published for Opposition
2012-05-24	Location: INTENT TO USE SECTION
2014-06-23	Abandon
2014-06-23	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Warner-Lambert Company LLC
Address	235 East 42nd Street New York DE 10017
Legal Entity Type	Limited Liability Company
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

KATRINA EDGE
PFIZER INC.
150 East 42nd Street / 2nd Floor
NEW YORK, NY 10017-5642

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Type Code

Type

GS0051

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2011-01-01	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2011-01-05	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2011-02-15	3 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT -WRITTEN	2011-02-15	4 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2011-02-15	5 GNEA F:First Action
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2011-02-15	6 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2011-02-15	7 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2011-02-15	8 CNSA P:
ASSIGNED TO LIE	2011-02-17	9 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2011-02-17	10 PREV O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2011-03-22	11 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2011-03-22	12 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2011-05-17	13 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2011-11-09	14 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2011-11-09	15 EXT1 S:
EXTENSION 1 GRANTED	2011-11-09	16 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2011-11-11	17 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2012-05-04	18 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2012-05-24	19 AITU A:Allowance for Publication
EXTENSION 2 FILED	2012-05-04	20 EXT2 S:
EXTENSION 2 GRANTED	2012-05-30	21 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2012-05-31	22 EXRA E:E-Mail
ASSIGNED TO EXAMINER	2012-07-02	23 DOCK D:Assigned to Examiner
TEAS EXTENSION RECEIVED	2012-11-14	24 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2012-11-14	25 EXT3 S:
EXTENSION 3 GRANTED	2012-11-16	26 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2012-11-17	27 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2013-05-15	28 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2013-05-15	29 EXT4 S:
EXTENSION 4 GRANTED	2013-05-21	30 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-05-22	31 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2013-10-30	32 EEXT I:Incoming Correspondence
EXTENSION 5 FILED	2013-10-30	33 EXT5 S:
EXTENSION 5 GRANTED	2013-11-06	34 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2013-11-07	35 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2014-06-23	36 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2014-06-23	37 MAB6 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
BESORFIB 98144113 not registered Live/Pending	Pfizer Inc. 2023-08-22
BESORFIB 88873862 not registered Live/Pending	Pfizer Inc. 2020-04-15
BESORFIB 87293657 not registered Live/Pending	Pfizer Inc. 2017-01-09
BESORFIB 86142823 5386845 Live/Registered	Pfizer Inc. 2013-12-13
BESORFIB 85207037 not registered Dead/Abandoned	Warner-Lambert Company LLC 2010-12-29
BESORFIB 78884767 not registered Dead/Abandoned	Warner-Lambert Company LLC 2006-05-16
BESORFIB 77767296 not registered Dead/Abandoned	Warner-Lambert Company LLC 2009-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.